Study on unexplained acute hepatitis detection and diagnosis
Part of Digestive system, Infections clinical trials.
This study looks for causes of acute hepatitis that doctors cannot explain yet. If you have symptoms of hepatitis but standard tests don't show the reason, this trial may help find new causes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have symptoms of acute hepatitis (like yellow skin, dark urine, or tiredness).
- Doctors suspect hepatitis but don't know what is causing it.
- You may have a new or unknown virus or another cause of hepatitis.
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial studies what happens to people with hepatitis B who have hepatitis B surface antigen for more than 6 months, are “HBeAg-negative,” and have certain blood and liver-scarring levels despite normal or near-normal liver inflammation. It may help doctors understand the best care for this specific group before clear treatment phases.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This trial is for children and teens (0–17 years) who are in the hospital or emergency department with acute hepatitis (sudden liver inflammation). The study aims to learn more about the condition and how to best treat it.
This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.
This study collects a small sample of liver cells to understand how hepatitis B virus behaves in the liver and how the immune system responds. This could help improve future treatments for chronic hepatitis B.
Hear when a new Hepatitis of Unknown Aetiology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.